Subjective Smell Disturbances in Children with Sars-Cov-2 or Other Viral Infections do not Correspond with Olfactory Test Results.

IF 0.9 4区 医学 Q3 PEDIATRICS Klinische Padiatrie Pub Date : 2024-02-01 Epub Date: 2024-01-23 DOI:10.1055/a-2208-6245
Hanna Grote, Anna Hoffmann, Sebastian Kerzel, Hannah Lukasik, Christoph Maier, Claire Mallon, Anne Schlegtendal, Michaela Schwarzbach, Konstantin van Ackeren, Stefan Volkenstein, Folke Brinkmann
{"title":"Subjective Smell Disturbances in Children with Sars-Cov-2 or Other Viral Infections do not Correspond with Olfactory Test Results.","authors":"Hanna Grote, Anna Hoffmann, Sebastian Kerzel, Hannah Lukasik, Christoph Maier, Claire Mallon, Anne Schlegtendal, Michaela Schwarzbach, Konstantin van Ackeren, Stefan Volkenstein, Folke Brinkmann","doi":"10.1055/a-2208-6245","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Olfactory dysfunction associated with SARS-CoV-2 infection in children has not been verified by a validated olfactory test. We aimed to determine whether these complaints are objectifiable (test-based hyposmia), how often they occur during acute SARS-CoV-2 infection compared to other upper respiratory tract infections (URTI), as well as in children recovered from COVID-19 compared to children with long COVID.</p><p><strong>Methods: </strong>Olfactory testing (U-sniff test; hyposmia<8 points) and survey-based symptom assessments were performed in 434 children (5-17 years; 04/2021-06/2022). 186 symptom-free children served as controls. Of the children with symptoms of acute respiratory tract infection, SARS-CoV-2 PCR test results were positive in 45 and negative in 107 children (URTI group). Additionally, 96 children were recruited at least 4 weeks (17.6±15.2 weeks) after COVID-19, of whom 66 had recovered and 30 had developed long COVID.</p><p><strong>Results: </strong>Compared to controls (2.7%), hyposmia frequency was increased in all other groups (11-17%, p<0.05), but no between-group differences were observed. Only 3/41 children with hyposmia reported complaints, whereas 13/16 children with complaints were normosmic, with the largest proportion being in the long-COVID group (23%, p<0.05).</p><p><strong>Conclusion: </strong>Questionnaires are unsuitable for assessing hyposmia frequency in children. Olfactory complaints and hyposmia are not specific for SARS-CoV-2 infection. The number of complaints in the long-COVID group could result from aversive olfactory perception, which is undetectable with the U-sniff test.</p>","PeriodicalId":17846,"journal":{"name":"Klinische Padiatrie","volume":" ","pages":"129-138"},"PeriodicalIF":0.9000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinische Padiatrie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2208-6245","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/23 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Olfactory dysfunction associated with SARS-CoV-2 infection in children has not been verified by a validated olfactory test. We aimed to determine whether these complaints are objectifiable (test-based hyposmia), how often they occur during acute SARS-CoV-2 infection compared to other upper respiratory tract infections (URTI), as well as in children recovered from COVID-19 compared to children with long COVID.

Methods: Olfactory testing (U-sniff test; hyposmia<8 points) and survey-based symptom assessments were performed in 434 children (5-17 years; 04/2021-06/2022). 186 symptom-free children served as controls. Of the children with symptoms of acute respiratory tract infection, SARS-CoV-2 PCR test results were positive in 45 and negative in 107 children (URTI group). Additionally, 96 children were recruited at least 4 weeks (17.6±15.2 weeks) after COVID-19, of whom 66 had recovered and 30 had developed long COVID.

Results: Compared to controls (2.7%), hyposmia frequency was increased in all other groups (11-17%, p<0.05), but no between-group differences were observed. Only 3/41 children with hyposmia reported complaints, whereas 13/16 children with complaints were normosmic, with the largest proportion being in the long-COVID group (23%, p<0.05).

Conclusion: Questionnaires are unsuitable for assessing hyposmia frequency in children. Olfactory complaints and hyposmia are not specific for SARS-CoV-2 infection. The number of complaints in the long-COVID group could result from aversive olfactory perception, which is undetectable with the U-sniff test.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Sars-Cov-2 或其他病毒感染患儿的主观嗅觉障碍与嗅觉测试结果不符。
背景:与儿童感染 SARS-CoV-2 相关的嗅觉功能障碍尚未得到有效嗅觉测试的验证。我们的目的是确定这些症状是否客观存在(基于测试的嗅觉减退),与其他上呼吸道感染(URTI)相比,这些症状在急性 SARS-CoV-2 感染期间发生的频率有多高,以及与长期 COVID 的儿童相比,在 COVID-19 恢复期的儿童中发生的频率有多高:方法:嗅觉测试(U-嗅觉测试;低嗅觉):结果:与对照组(2.7%)相比,其他各组的嗅觉减退频率均有所增加(11-17%,p):调查问卷不适合用于评估儿童的嗅觉减退频率。嗅觉不适和嗅觉减退不是 SARS-CoV-2 感染的特异性症状。长COVID组中的主诉数量可能是由于厌恶性嗅觉感知造成的,而这种感知在U-嗅觉测试中是检测不到的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Klinische Padiatrie
Klinische Padiatrie 医学-小儿科
CiteScore
1.10
自引率
0.00%
发文量
135
审稿时长
6-12 weeks
期刊介绍: Das Forum für wissenschaftliche Information in der Kinderheilkunde ausgewählte Originalarbeiten aus allen Bereichen der Pädiatrie Visite: Ihr Forum für interessante Krankengeschichten und außergewöhnliche Kasuistiken aktuelle Fortschritte in Diagnostik und Therapie jährliche Schwerpunkthefte: Ergebnisse der pädiatrischen Onkologie plus Medizin und Markt topaktuelle Informationen aus der Industrie
期刊最新文献
[Influenza vaccination in healthy infants Should healthy infants be included in the vaccination recommendations?] Co-occurrence of Gluten-free Diet Adherence on Bone Mineral Density and Growth in Children with Celiac Disease. [Treatment of RSV in pediatric inpatients (Leave 5) and early effects of nirsevimab passive immunization in a regional German pediatric network]. Wolcott-Rallison Syndrome: A Case Report with Novel Homozygous EIF2AK3 Gene Mutation. Clinical Course of Hyperostosis Due to SP7 (Osterix) Gain-of Function Mutation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1